- Trials with a EudraCT protocol (16)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
16 result(s) found for: Aminoglycoside.
Displaying page 1 of 1.
EudraCT Number: 2014-002387-32 | Sponsor Protocol Number: UoL001019 | Start Date*: 2014-08-05 | |||||||||||||||||||||
Sponsor Name:University of Liverpool | |||||||||||||||||||||||
Full Title: Phase IIa, Randomised, Controlled, Open-Label Trial of Rosuvastatin for the Prevention of Aminoglycoside-Induced Kidney Toxicity in Children with Cystic Fibrosis | |||||||||||||||||||||||
Medical condition: Aminoglycoside-induced nephrotoxicity | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-003016-32 | Sponsor Protocol Number: APHP180690 | Start Date*: 2020-01-24 |
Sponsor Name:Assistance Publique – Hôpitaux de Paris | ||
Full Title: Impact of aminoglycosides-based antibiotics combination and protective isolation on outcomes in critically-ill neutropenic patients with sepsis:A randomized 2 by 2 factorial design randomized pragm... | ||
Medical condition: neutropenic patients with sepsis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004211-30 | Sponsor Protocol Number: 2005-23 | Start Date*: 2005-10-17 |
Sponsor Name:The Norwegian Radium Hospital | ||
Full Title: Penicillin G and an aminoglycoside versus meropenem as initial empiric antibiotic therapy in lymphoma and leukemia patients with febrile neutropenia | ||
Medical condition: Lymphoma and leukemia patients with febrile neutropenia | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005110-41 | Sponsor Protocol Number: 9999999999999999999 | Start Date*: 2008-12-09 |
Sponsor Name:not applicable | ||
Full Title: Circadian Influence on Renal Clearance of Aminoglycosides in cystic fibrosis patients | ||
Medical condition: Repeated or extended dosing of aminoglycosides may cause damage to the proximal tubuli, resulting in renal impairment. Renal impairment affects up to 40 % of adult CF patients, measured after estim... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004437-16 | Sponsor Protocol Number: tobra-02 | Start Date*: 2013-05-15 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Pharmacokinetic evaluation and tolerability of dry powder tobramycin by a novel device in patients with non cystic fibrosis bronchiectasis | ||
Medical condition: Bronchiectasis Lung infections | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001840-83 | Sponsor Protocol Number: SAGA | Start Date*: 2022-04-26 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: Short-course aminoglycosides as adjunctive treatment in adults with sepsis | ||
Medical condition: Patients admitted with sepsis of unknown origin, suspected urinary origin or suspected abdominal origin | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000338-10 | Sponsor Protocol Number: 0606 | Start Date*: 2006-02-24 |
Sponsor Name:NHS Lothian Health Board [...] | ||
Full Title: Can long term nebulised gentamicin reduce the bacterial burden, break the vicious cycle of inflammation and improve quality of life in patients with bronchiectasis? | ||
Medical condition: Bronchiectasis is respiratory disease with damaged airways. Such patients have frequent bacterial chest infections. The aim of our study is to assess whether nebulised gentamicin 80mg twice daily w... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-023030-23 | Sponsor Protocol Number: 10076 | Start Date*: 2010-12-24 |
Sponsor Name:The Univeristy of Nottingham [...] | ||
Full Title: Circadian Rhythm In Tobramycin Elimination in Cystic Fibrosis (CRITIC) - a Randomised Pharmacokinetic Comparison of Tobramycin in CF | ||
Medical condition: Cystic fibrosis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-004986-99 | Sponsor Protocol Number: NBTCS02 | Start Date*: 2017-01-11 | |||||||||||
Sponsor Name:NovaBiotics, Ltd | |||||||||||||
Full Title: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients with Cystic Fibrosis (C... | |||||||||||||
Medical condition: exacerbation of Cystic Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000546-30 | Sponsor Protocol Number: Rempex-506 | Start Date*: 2015-04-21 | |||||||||||||||||||||||||||||||
Sponsor Name:Rempex Pharmaceuticals, Inc. | |||||||||||||||||||||||||||||||||
Full Title: A PHASE 3, MULTI-CENTER, RANDOMIZED, OPEN-LABEL STUDY OF CARBAVANCE (MEROPENEM/RPX7009) VERSUS BEST AVAILABLE THERAPY IN SUBJECTS WITH SELECTED SERIOUS INFECTIONS DUE TO CARBAPENEM RESISTANT ENTERO... | |||||||||||||||||||||||||||||||||
Medical condition: serious infections, specifically complicated urinary tract infection (cUTI) or acute pyelonephritis (AP), complicated intra-abdominal infections (cIAI), hospital acquired bacterial pneumonia (HABP... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) IT (Completed) ES (Completed) GR (Completed) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007940-92 | Sponsor Protocol Number: TR02-107 | Start Date*: 2008-12-12 | |||||||||||
Sponsor Name:Transave, Inc. | |||||||||||||
Full Title: A PLACEBO CONTROLLED, RANDOMIZED, PARALLEL COHORT, SAFETY AND TOLERABILITY STUDY OF TWO DOSE LEVELS OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE™) IN PATIENTS WITH BRONCHIECTASIS COMPLICATED BY CH... | |||||||||||||
Medical condition: Bronchiectasis Complicated by Chronic Infection due to Pseudomonas aeruginosa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) HU (Completed) GR (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006980-22 | Sponsor Protocol Number: TR02-105 | Start Date*: 2007-06-14 | |||||||||||
Sponsor Name:Transave, Inc. | |||||||||||||
Full Title: MULTIDOSE SAFETY AND TOLERABILITY STUDY OF DOSE ESCALATION OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE™) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTIONS DUE TO PSEUDOMONAS AERUGINOSA | |||||||||||||
Medical condition: Cystic fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) SK (Completed) BE (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000450-21 | Sponsor Protocol Number: MONS4STRAT | Start Date*: 2018-04-09 |
Sponsor Name:Fundación Investigación Biomédica Hospital Ramón y Cajal | ||
Full Title: Prospective, Randomized, Open, Controlled, Multicenter Study to Evaluate the Safety and Efficacy of the MON4STRAT Approach for Optimizing Meropenem Therapy in Intubated and Mechanically-Ventilated,... | ||
Medical condition: Nosocomial pneumonia or severe tracheobronchitis caused by Gram-negative pathogens in subjects that requiring mechanical ventilation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004486-37 | Sponsor Protocol Number: 59812 | Start Date*: 2017-09-19 | ||||||||||||||||
Sponsor Name:University Medical Centre Utrecht | ||||||||||||||||||
Full Title: FOsfomycin Randomised controlled trial for E.coli Complicated urinary tract infections as Alternative Stepdown Treatment | ||||||||||||||||||
Medical condition: Acute febrile urinary tract infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003483-46 | Sponsor Protocol Number: 10-0060+EU-Appendix5.0,11.12.2014 | Start Date*: 2013-11-12 | |||||||||||
Sponsor Name:University of Florida Board of Trustees | |||||||||||||
Full Title: Impact of Aggressive Empiric Antibiotic Therapy and Duration of Therapy on the Emergence of Antimicrobial Resistance during the Treatment of Hospitalized Subjects with Pneumonia Requiring Mechanica... | |||||||||||||
Medical condition: pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004544-38 | Sponsor Protocol Number: C3601009 | Start Date*: 2020-07-03 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: A PROSPECTIVE, RANDOMIZED, OPEN-LABEL, COMPARATIVE STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF AZTREONAM-AVIBACTAM (ATM-AVI) AND BEST AVAILABLE THERAPY FOR THE TREATMENT OF SERIOUS INF... | |||||||||||||
Medical condition: SERIOUS INFECTIONS DUE TO MULTI-DRUG RESISTANT GRAM- NEGATIVE BACTERIA PRODUCING METALLO-Β-LACTAMASE (MBL) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Prematurely Ended) RO (Ongoing) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.